Andes Technology Valuation
Is ANDS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ANDS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ANDS ($22.4) is trading below our estimate of fair value ($23.66)
Significantly Below Fair Value: ANDS is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ANDS?
Other financial metrics that can be useful for relative valuation.
What is ANDS's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | NT$18.69b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 15.3x |
Enterprise Value/EBITDA | -119.3x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does ANDS's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 4x | ||
8028 Phoenix Silicon International | 6.2x | n/a | NT$19.9b |
3016 Episil-Precision | 3.9x | n/a | NT$18.0b |
003040 Chutian Dragon | 3.9x | 10.5% | CN¥4.9b |
300102 Xiamen Changelight | 2.2x | n/a | CN¥5.4b |
ANDS Andes Technology | 17.9x | 28.5% | US$18.7b |
Price-To-Sales vs Peers: ANDS is expensive based on its Price-To-Sales Ratio (17.9x) compared to the peer average (4x).
Price to Earnings Ratio vs Industry
How does ANDS's PE Ratio compare vs other companies in the European Semiconductor Industry?
Price-To-Sales vs Industry: ANDS is expensive based on its Price-To-Sales Ratio (17.9x) compared to the European Semiconductor industry average (2.2x).
Price to Sales Ratio vs Fair Ratio
What is ANDS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 17.9x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate ANDS's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.